FDA Inspection 1190843 — Shady Grove Reproductive Science Center PC
The FDA completed an inspection of Shady Grove Reproductive Science Center PC on November 4, 2022 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 4, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Washington, DC (United States)